VanEck Associates
QGENF

VanEck Associates’s QIAGEN NV QGENF Stock Holding History

VanEck Associates’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-526,746
Closed -$14.8M – 928
2016
Q4 		$14.8M Buy
526,746
+15,918
+3% +$446K 0.07% 171
2016
Q3 		$14M Sell
510,828
-109,907
-18% -$3.02M 0.07% 174
2016
Q2 		$13.5M Sell
620,735
-136,813
-18% -$2.98M 0.07% 168
2016
Q1 		$16.9M Buy
757,548
+84,501
+13% +$1.89M 0.11% 133
2015
Q4 		$18.6M Buy
673,047
+85,674
+15% +$2.37M 0.15% 136
2015
Q3 		$15.2M Sell
587,373
-116,549
-17% -$3.01M 0.12% 150
2015
Q2 		$17.4M Buy
703,922
+19,565
+3% +$485K 0.1% 162
2015
Q1 		$17.2M Sell
684,357
-85,613
-11% -$2.16M 0.1% 158
2014
Q4 		$18.1M Buy
769,970
+26,176
+4% +$614K 0.11% 147
2014
Q3 		$16.9M Sell
743,794
-54,658
-7% -$1.24M 0.09% 162
2014
Q2 		$19.5M Sell
798,452
-145,663
-15% -$3.56M 0.09% 148
2014
Q1 		$19.9M Buy
944,115
+299,627
+46% +$6.32M 0.1% 138
2013
Q4 		$15.3M Buy
644,488
+88,829
+16% +$2.11M 0.08% 147
2013
Q3 		$11.9M Buy
555,659
+4,680
+0.8% +$100K 0.06% 160
2013
Q2 		$11M Buy
+550,979
New +$11M 0.06% 161

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

VanEck Associates's QGENF Position: Q1 2017 in Review

VanEck Associates sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 526,746 shares — an estimated $14.8M sold.

VanEck Associates first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $19.9M in Q1 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • VanEck Associates reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • VanEck Associates sold 526,746 QIAGEN NV shares in Q1 2017, an estimated $14.8M.
  • VanEck Associates first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • VanEck Associates's QIAGEN NV position peaked at $19.9M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on VanEck Associates's 13F filing for Q1 2017, filed 11 May 2017.